IBDEI11S ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16840,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,16841,0)
 ;;=N70.91^^88^881^75
 ;;^UTILITY(U,$J,358.3,16841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16841,1,3,0)
 ;;=3^Salpingitis,Unspec
 ;;^UTILITY(U,$J,358.3,16841,1,4,0)
 ;;=4^N70.91
 ;;^UTILITY(U,$J,358.3,16841,2)
 ;;=^5015806
 ;;^UTILITY(U,$J,358.3,16842,0)
 ;;=N70.93^^88^881^74
 ;;^UTILITY(U,$J,358.3,16842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16842,1,3,0)
 ;;=3^Salpingitis & Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,16842,1,4,0)
 ;;=4^N70.93
 ;;^UTILITY(U,$J,358.3,16842,2)
 ;;=^5015808
 ;;^UTILITY(U,$J,358.3,16843,0)
 ;;=N70.92^^88^881^55
 ;;^UTILITY(U,$J,358.3,16843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16843,1,3,0)
 ;;=3^Oophoritis,Unspec
 ;;^UTILITY(U,$J,358.3,16843,1,4,0)
 ;;=4^N70.92
 ;;^UTILITY(U,$J,358.3,16843,2)
 ;;=^5015807
 ;;^UTILITY(U,$J,358.3,16844,0)
 ;;=N73.9^^88^881^37
 ;;^UTILITY(U,$J,358.3,16844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16844,1,3,0)
 ;;=3^Inflammatory Disease Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,16844,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,16844,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,16845,0)
 ;;=A56.11^^88^881^36
 ;;^UTILITY(U,$J,358.3,16845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16845,1,3,0)
 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
 ;;^UTILITY(U,$J,358.3,16845,1,4,0)
 ;;=4^A56.11
 ;;^UTILITY(U,$J,358.3,16845,2)
 ;;=^5000342
 ;;^UTILITY(U,$J,358.3,16846,0)
 ;;=N73.5^^88^881^64
 ;;^UTILITY(U,$J,358.3,16846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16846,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,16846,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,16846,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,16847,0)
 ;;=N72.^^88^881^35
 ;;^UTILITY(U,$J,358.3,16847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16847,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,16847,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,16847,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,16848,0)
 ;;=N76.3^^88^881^92
 ;;^UTILITY(U,$J,358.3,16848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16848,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,16848,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,16848,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,16849,0)
 ;;=N76.1^^88^881^88
 ;;^UTILITY(U,$J,358.3,16849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16849,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,16849,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,16849,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,16850,0)
 ;;=N76.2^^88^881^91
 ;;^UTILITY(U,$J,358.3,16850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16850,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,16850,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,16850,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,16851,0)
 ;;=N76.0^^88^881^87
 ;;^UTILITY(U,$J,358.3,16851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16851,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,16851,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,16851,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,16852,0)
 ;;=M00.20^^88^881^3
 ;;^UTILITY(U,$J,358.3,16852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16852,1,3,0)
 ;;=3^Arthritis Streptococcal,Unspec Joint
 ;;^UTILITY(U,$J,358.3,16852,1,4,0)
 ;;=4^M00.20
 ;;^UTILITY(U,$J,358.3,16852,2)
 ;;=^5009645
 ;;^UTILITY(U,$J,358.3,16853,0)
 ;;=M00.80^^88^881^4
 ;;^UTILITY(U,$J,358.3,16853,1,0)
 ;;=^358.31IA^4^2
